Katherine Cheng, MD

Title(s)CLINICAL FELLOW, Radiology
SchoolSchool of Medicine
Address185 Berry Street Bldg B
San Francisco CA 94158
Phone--
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Not everything that counts can be counted: Tracking long-term outcomes in pediatric liver transplant recipients. Am J Transplant. 2022 04; 22(4):1182-1190. Cheng K, Feng S, Bucuvalas JC, Levitsky J, Perito ER. PMID: 34951518; PMCID: PMC8983571.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Liver transplant in children and adults with cystic fibrosis: Impact of growth failure and nutritional status. Am J Transplant. 2022 01; 22(1):177-186. Cheng K, Rosenthal P, Roberts JP, Perito ER. PMID: 34379865.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites. Ann Diagn Pathol. 2015 Jun; 19(3):146-8. Cheng KA, Kurtis B, Babayeva S, Zhuge J, Tantchou I, Cai D, Lafaro RJ, Fallon JT, Zhong M. PMID: 25862495.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    4. Failure to induce apoptosis via BCL-2 family proteins underlies lack of efficacy of combined MEK and PI3K inhibitors for KRAS-mutant lung cancers. Cancer Res. 2014 Jun 01; 74(11):3146-56. Hata AN, Yeo A, Faber AC, Lifshits E, Chen Z, Cheng KA, Walton Z, Sarosiek KA, Letai A, Heist RS, Mino-Kenudson M, Wong KK, Engelman JA. PMID: 24675361; PMCID: PMC4046322.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    5. Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer. Clin Cancer Res. 2013 Nov 15; 19(22):6183-92. Shimamura T, Chen Z, Soucheray M, Carretero J, Kikuchi E, Tchaicha JH, Gao Y, Cheng KA, Cohoon TJ, Qi J, Akbay E, Kimmelman AC, Kung AL, Bradner JE, Wong KK. PMID: 24045185; PMCID: PMC3838895.
      View in: PubMed   Mentions: 97     Fields:    Translation:AnimalsCells
    6. Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models. Cancer Cell. 2013 Jan 14; 23(1):121-8. Corcoran RB, Cheng KA, Hata AN, Faber AC, Ebi H, Coffee EM, Greninger P, Brown RD, Godfrey JT, Cohoon TJ, Song Y, Lifshits E, Hung KE, Shioda T, Dias-Santagata D, Singh A, Settleman J, Benes CH, Mino-Kenudson M, Wong KK, Engelman JA. PMID: 23245996; PMCID: PMC3667614.
      View in: PubMed   Mentions: 193     Fields:    Translation:HumansAnimals
    7. Combined EGFR/MET or EGFR/HSP90 inhibition is effective in the treatment of lung cancers codriven by mutant EGFR containing T790M and MET. Cancer Res. 2012 Jul 01; 72(13):3302-11. Xu L, Kikuchi E, Xu C, Ebi H, Ercan D, Cheng KA, Padera R, Engelman JA, Jänne PA, Shapiro GI, Shimamura T, Wong KK. PMID: 22552292; PMCID: PMC3389159.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    8. Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition. Nat Med. 2011 Jun 26; 17(7):875-82. Johnson N, Li YC, Walton ZE, Cheng KA, Li D, Rodig SJ, Moreau LA, Unitt C, Bronson RT, Thomas HD, Newell DR, D'Andrea AD, Curtin NJ, Wong KK, Shapiro GI. PMID: 21706030; PMCID: PMC3272302.
      View in: PubMed   Mentions: 137     Fields:    Translation:HumansAnimalsCells
    Katherine's Networks
    Concepts (87)
    Derived automatically from this person's publications.
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _